Navigation Links
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
Date:7/2/2009

PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration (FDA) has approved Multaq(R) (dronedarone) 400 mg Tablets. Patients with atrial fibrillation (AF) or atrial flutter (AFL) soon will have a new treatment option to help improve current management of their disease. Multaq(R) is the first drug approved in the United States that has shown a clinical benefit to reduce cardiovascular hospitalization in patients with AF/AFL.

Multaq(R) is an anti-arrhythmic indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL), with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted. Associated cardiovascular risk factors include age over 70 years, hypertension, diabetes, prior cerebrovascular accident, left atrial diameter greater than or equal to 50 mm or left ventricular ejection fraction [LVEF] <40%. The FDA approval is based on five international, multi-center, randomized clinical trials involving nearly 6,300 patients.

"The FDA approval of Multaq(R) is an important milestone in the management of atrial fibrillation or atrial flutter that demonstrates the commitment of sanofi-aventis to provide patients and physicians with important new medicines in therapeutic areas with significant healthcare needs," said Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis. "Sanofi-aventis is proud of its ability to bring innovative therapies to market and contribute to reducing the public health burden of atrial fibrillation."

The landmark ATHENA trial evaluated the efficacy and safety of Multaq(R) in patients with AF/AFL or a recent history
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
2. FDA Approves Reclast(R) to Prevent Osteoporosis in Postmenopausal Women With Convenient Less Frequent Dosing
3. FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
4. ClearWay Minnesota(SM) Board Approves Four Regional Grants
5. Department of Defense Approves ISSA as Fitness Education Provider to Military Spouses
6. FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
7. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
8. FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
9. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
10. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
11. FDA Approves Plan B Pill for 17-Year-Olds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Case Medical Center clinical researchers have launched an ... will evaluate the ability of a patient,s own ... stage peripheral arterial disease (PAD). , Led ... at University Hospitals Case Medical Center,s Harrington Heart ... Case Western Reserve University School of Medicine, the ...
(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
(Date:6/18/2013)... have discovered and mapped the signaling network between two ... could cut off cancer cell growth at its starting ... University of Texas MD Anderson Cancer Center reported the ... cancer drug target, and MCM7, a protein vital to ... issue of Cancer Cell . , "MCM7 overexpression ...
(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...
(Date:6/18/2013)... CA (PRWEB) June 18, 2013 The July ... “The Cheater’s Guide to Getting Beach Ready,” offers a list ... to look their best in a bathing suit this summer. ... skin firming , smoothing cellulite , and more. ... Simon Ourian, Medical Director of Epione Beverly Hills, “though I ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:SimuCase avatars advance speech-language pathology training 2Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:Allsup Observes National HIV Testing Day June 27 2Health News:Allsup Observes National HIV Testing Day June 27 3Health News:Skin Care – Getting Your Body Beach Ready 2
... , , WEDNESDAY, Nov. 7 (HealthDay News) -- Brain development is ... shows. , The slowdown in brain development is similar to ... Babies who require heart surgery have long been known to ... the surgery or other factors has been in debate. , ...
... Cost, language barriers often to blame, study finds , ... statin drugs are known to be effective, many patients ... factors may be to blame. , In their study, ... They found that statin discontinuation rates among more than ...
... NEWPORT NEWS, Va., Nov. 7 This past ... Opposing Compact Gamma,Cameras" were presented at the Nuclear ... The goal of the laboratory study was ... camera system in a configuration in which,the two ...
... Health Informatics, From,Foundations to Applications to Policy, ... American Medical,Informatics Association (AMIA) 31st Annual Symposium, ... in biomedical and health,informatics starts Friday. Experts ... privacy and security of electronic health information,transparency ...
... WASHINGTON, Nov. 7 Today, the release ... Reduce Teen,Pregnancy and Sexually Transmitted Disease, a report ... adolescent health, confirmed, once,again, that the $1.5 billion ... waste of taxpayer money., The report, commissioned ...
... First to Taste Missy Chase Lapine,s New Kid-Friendly, Kid-Healthy Dishes, Now Added to the ... Cynthia Sparer, executive director, Morgan Stanley ... member Family Advisory Council, Morgan ... Missy Chase Lapine, Patients and ...
Cached Medicine News:Health News:Heart Defects Can Delay Baby's Brain Development 2Health News:Heart Defects Can Delay Baby's Brain Development 3Health News:Heart Defects Can Delay Baby's Brain Development 4Health News:Many Patients Stop Taking Cholesterol-Lowering Drugs 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 2Health News:Dilon Technologies Explores Improvements in Molecular Breast Imaging 3Health News:AMIA's 31st Annual Symposium Opens in Chicago, IL 2Health News:AMIA's 31st Annual Symposium Opens in Chicago, IL 3Health News:New Study - Same Verdict 2Health News:Sneaky Chef's Recipes Make Delicious Debut at Morgan Stanley Children's Hospital 2
(Date:6/18/2013)... 18, 2013  Actavis, Inc. (NYSE: ACT ) ... the U.S. Securities and Exchange Commission (SEC) a registration statement ... Warner Chilcott plc (NASDAQ: WCRX ), ... Warner Chilcott (the "Form S-4"). As previously ... have entered into a definitive agreement pursuant to which ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
(Date:6/18/2013)... ANDOVER, Mass. , June 18, 2013 ... announced the company was named Overall Performance Leader in ... Medical Equipment & Infrastructure report. Philips also received Best ... of its imaging products: Ingenuity Core 128 Computed ... iE33 ultrasound and PageWriter TC70 cardiograph. The annual Best ...
Breaking Medicine Technology:Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 2Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 3Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 4Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 5Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 6Actavis Files Registration Statement on Form S-4 in Connection with Proposed Warner Chilcott Acquisition 7Philips Named 2013 Overall Performance Leader In Imaging Equipment By KLAS 2
... 2012  Based on its recent analysis of the ... recognizes Sensear with the 2012 North American Frost ... its "high-noise communication" devices, including earplugs and earmuffs ... still enabling the user to remain fully aware ...
... Carla Corkern, Chief Executive Officer at Talyst , was ... recognizes entrepreneurs whose ingenuity, hard work and perseverance have created ... originated in 1986 and has grown to 26 programs in ... the world. "Talyst is a leader in ...
Cached Medicine Technology:Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 2Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 3Frost & Sullivan Recognizes Sensear for Innovative and Effective Product Differentiation in the PPE Market 4
... Non-Donor Screen. Vironostika HIV assays provide superior ... testing and confirmation. Vironostika HIV-1 Microelisa ... the detection of antibody to HIV-1 in ... Oral Fluid Vironostika HIV-1 Microelisa System is ...
... Rapid Immunoassay: Uni-Gold Recombigen HIV is a single ... to HIV-1 in plasma, serum and whole blood ... in point of care settings as an aid ... is suitable for use in appropriate multi-test algorithms ...
... an OraSure HIV-1 Oral Specimen Collection Device is ... for HIV-1 antibodies. Testing with the OraSure HIV-1 ... needles and has been shown to be more ... specially treated cotton fiber pad attached to a ...
The Becton™ Colles Fracture Plate has proven clinical outcomes and has excellent patient acceptance compared to external fixation. It provides a cost effective treatment option through a simple...
Medicine Products: